The nascent role of circulating tumour DNA in the management of non‐muscle‐invasive bladder cancer

Ähnliche Einträge

• Quality of transurethral resection of bladder tumour documentation: implications for non‐muscle‐invasive bladder cancer risk stratification and management
  von: Abram Botros, et al.
  Veröffentlicht: (2024)
• Understanding patient perspectives in the management of their muscle‐invasive bladder cancer
  von: Deepro Chowdhury, et al.
  Veröffentlicht: (2025)
• Improving the pathway to correct treatment for patients with muscle‐invasive bladder cancer: exploring the myths around the BladderPath trial
  von: Richard T. Bryan, et al.
  Veröffentlicht: (2025)
• Advances in the management of high‐risk localised muscle invasive bladder cancer
  Veröffentlicht: (2025)
• Refining BCG ‐failure classifications in non‐muscle‐invasive bladder cancer
  von: Aleksander Ślusarczyk, et al.
  Veröffentlicht: (2026)